Edition:
United Kingdom

Momenta Pharmaceuticals Inc (MNTA.OQ)

MNTA.OQ on NASDAQ Stock Exchange Global Select Market

26.90USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$26.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
161,278
52-wk High
$32.15
52-wk Low
$11.85

Chart for

About

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. The Company has developed generic version of LOVENOX (enoxaparin sodium injection) and COPAXONE (glatiramer acetate injection). GLATOPA 20... (more)

Overall

Beta: 1.76
Market Cap(Mil.): $987.19
Shares Outstanding(Mil.): 76.23
Dividend: --
Yield (%): --

Financials

  MNTA.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.61 -- --
ROI: -11.12 1.79 14.61
ROE: -12.38 3.28 16.33

BRIEF-Momenta Pharmaceuticals Q1 Loss Per Share $0.63

* MOMENTA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08 May 2018

Competitors

Earnings vs. Estimates